The Impact of Music and Memory on Resident Level Outcomes in California Nursing Homes
- PMID: 32146039
- PMCID: PMC8121202
- DOI: 10.1016/j.jamda.2020.01.103
The Impact of Music and Memory on Resident Level Outcomes in California Nursing Homes
Abstract
Objectives: To study the effects of a nonpharmacologic intervention, Music and Memory (M&M), on residents with dementia and/or behavioral problems living in nursing homes (NHs).
Design: This was a prospective, mixed-methods cohort study.
Setting and participants: In total, 4107 residents in 265 California NHs and that reported data at least twice during the 3-year study period were enrolled.
Measures: We used a quarterly rolling enrollment process; participants provided data at baseline and quarterly via an online survey that included select resident level data from the Minimum Data Set (psychotropic drug use, cognition, behaviors, mood, pain, and falls), experience with the M&M program, and resident use of music. NHs were eligible if they were Medicare- and Medicaid-certified and had 15 residents with a diagnosis of dementia or cognitive impairment or exhibited significant behavioral symptoms.
Results: M&M was associated with reductions in psychotropic medication use, reduced behaviors, and improved mood. The odds of antipsychotic use declined by about 11%, of antianxiety medications by 17%, and antidepressants by 9% per quarter. Aggressive behaviors, depressive symptoms, pain, and falls also declined significantly over time. The odds of residents exhibiting aggressive behaviors declined by 20% per quarter, depressive symptoms by 16%, reported pain by 17%, and falls by 8%.
Conclusions and implications: This is the largest study of M&M to date. We found clinically and statistically significant reductions in psychotropic medications and improved behaviors in residents using M&M. Although the study showed positive results overall, the lack of a control group was a significant limitation that precluded determining how much more improvement participating residents experienced compared with nonparticipants. Future studies should include a control group so that better conclusions can be drawn regarding the effectiveness of the M&M program.
Keywords: Dementia; antipsychotics; nonpharmacologic; nursing homes; psychotropics.
Copyright © 2020 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- 2019 Alzheimer’s Disease Facts and Figures Report. Available at: https://www.alz.org/documents/alzheimers-facts-and-figures-2019-r. Accessed January 4, 2020.
-
- Seitz DP, Brisbin S, Herrmann N, et al. Efficacy and feasibility of non-pharmacological interventions for neuropsychiatric symptoms of dementia in long term care: A systematic review. J Am Med Dir Assoc 2012;13:503–506. - PubMed
-
- Bonner A. Improving dementia care and reducing unnecessary use of antipsychotic medications in nursing homes. Baltimore: Center for Medicare and Medicaid Services, ed Medicare Learning Network; 2013.
-
- Cohen-Mansfield J, Mintzer JE. Time for change: The role of non-pharmacological interventions in treating behavior problems in nursing home residents with dementia. Alzheimer Dis Assoc Disord 2005;19:37–40. - PubMed
-
- Livingston G, Kelly L, Lewis-Holmes E, et al. Efficacy and feasibility of non-pharmacological interventions for agitation in dementia: Systematic review of randomised controlled trials. Br J Psychiatry 2014;205:436–442. - PubMed
